Cohort profile: the pharmacogenomics and pharmacokinetics study in Ghanaian HIV patients (GenoPharm-GH)
The project provides a strong avenue for translational HIV research, guiding policy and enhancing long-term results. Expanding biobanking and ongoing follow-up should help to improve knowledge of treatment outcomes, support individualised HIV treatment, and direct further therapeutic interventions. Participants are followed up and data updated at regular intervals to understand the dynamics of treatment outcome.
Authors
- Martins Ekor (ORCID: https://orcid.org/0000-0002-4683-0988)
- Samuel Badu Nyarko (ORCID: https://orcid.org/0000-0003-1104-7544)
- Akwasi Anyanful (ORCID: https://orcid.org/0000-0002-1666-8342)
- Nicholas Ekow Thomford (ORCID: https://orcid.org/0000-0002-3152-5817)
- George B. Kyei (ORCID: https://orcid.org/0000-0002-8678-4656)
- Oksana Ryabinina
- Joel Adu Twum
- John Anyimadu
Institutions
- University of Cape Coast (GH)
- University of Ghana (GH)
- University of Cape Town (ZA)
- Washington University in St. Louis (US)
- Noguchi Memorial Institute for Medical Research (GH)
Publication Details
- Journal
- BMC Genomic Data
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1186/s12863-025-01369-4
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00